Aethlon Medical Statistics
Total Valuation
AEMD has a market cap or net worth of $3.94 million. The enterprise value is -$3.43 million.
| Market Cap | 3.94M |
| Enterprise Value | -3.43M |
Important Dates
The last earnings date was Wednesday, February 14, 2024, after market close.
| Earnings Date | Feb 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AEMD has 2.62 million shares outstanding. The number of shares has increased by 9.67% in one year.
| Shares Outstanding | 2.62M |
| Shares Change (YoY) | +9.67% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 6.44% |
| Owned by Institutions (%) | 1.98% |
| Float | 2.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 0.21 |
| PS Ratio | 6.86 |
| Forward PS | n/a |
| PB Ratio | 0.52 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.93 |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.30% and return on invested capital (ROIC) is -151.49%.
| Return on Equity (ROE) | -106.30% |
| Return on Assets (ROA) | -86.60% |
| Return on Capital (ROIC) | -151.49% |
| Revenue Per Employee | $38,283 |
| Profits Per Employee | -$816,646 |
| Employee Count | 15 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.60% in the last 52 weeks. The beta is 1.94, so AEMD's price volatility has been higher than the market average.
| Beta (1Y) | 1.94 |
| 52-Week Price Change | -66.60% |
| 50-Day Moving Average | 1.65 |
| 200-Day Moving Average | 2.15 |
| Relative Strength Index (RSI) | 40.43 |
| Average Volume (30 Days) | 8,251 |
Short Selling Information
The latest short interest is 29,759, so 1.14% of the outstanding shares have been sold short.
| Short Interest | 29,759 |
| Short Previous Month | 18,923 |
| Short % of Shares Out | 1.14% |
| Short % of Float | 1.23% |
| Short Ratio (days to cover) | 1.81 |
Income Statement
In the last 12 months, AEMD had revenue of $574,245 and -$12.25 million in losses. Loss per share was -$5.09.
| Revenue | 574,245 |
| Gross Profit | 574,245 |
| Operating Income | -12.63M |
| Pretax Income | -12.25M |
| Net Income | -12.25M |
| EBITDA | -11.89M |
| EBIT | -12.25M |
| Loss Per Share | -$5.09 |
Balance Sheet
The company has $8.09 million in cash and $724,848 in debt, giving a net cash position of $7.37 million or $2.81 per share.
| Cash & Cash Equivalents | 8.09M |
| Total Debt | 724,848 |
| Net Cash | 7.37M |
| Net Cash Per Share | $2.81 |
| Equity / Book Value | 7.61M |
| Book Value Per Share | 2.90 |
| Working Capital | 6.15M |
Cash Flow
In the last 12 months, operating cash flow was -$10.51 million and capital expenditures -$257,249, giving a free cash flow of -$10.77 million.
| Operating Cash Flow | -10.51M |
| Capital Expenditures | -257,249 |
| Free Cash Flow | -10.77M |
| FCF Per Share | -$4.28 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,199.15% and -2,133.18%.
| Gross Margin | 100.00% |
| Operating Margin | -2,199.15% |
| Pretax Margin | -2,133.18% |
| Profit Margin | -2,133.18% |
| EBITDA Margin | -2,071.34% |
| EBIT Margin | -2,133.18% |
| FCF Margin | -1,875.22% |
Dividends & Yields
AEMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.67% |
| Shareholder Yield | -9.67% |
| Earnings Yield | -311.03% |
| FCF Yield | -273.41% |
Analyst Forecast
The average price target for AEMD is $10.00, which is 565.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 565.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 5, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 5, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
AEMD has an Altman Z-Score of -22.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.68 |
| Piotroski F-Score | 3 |